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Abstract: Introduction: Primary intramedullary spinal cord lymphomas are extremely 
rare, occurring mainly in immune compromised patients. Case report: We report a case 
of a 43 years old patient admitted with spinal cord compression. Spinal MRI revealed 
two thoracic intramedullary tumours. The patients underwent surgery and we 
performed resection of both primary intramedullary tumours, with favourable 
neurological outcome. The histopathologic exam was non-Hodgkin lymphoma. The 
patient underwent adjuvant radiotherapy. Two months later the patient presented 
thoracic and cerebellar drop metastases, confirmed histopathologically. Conclusions: The 
diagnosis of primary intramedullary spinal lymphoma must be kept in mind in patients 
with myelopathy. Surgery is needed to provide histopathological samples for positive 
diagnosis and spinal decompression. Primary intramedullary spinal lymphomas have a 
propensity to disseminate along the neuraxis.  
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Introduction 
Spinal cord lymphomas are rare. Spinal 
lymphomas are usually extradural, occurring 
in vertebral bodies or in epidural tissue.    
Primary intramedullary spinal cord 
lymphomas are very rare and accounts for 1% 
of CNS lymphomas.1,2 The majority of 
intramedullary lymphomas are secondary 
drop metastases. Some studies found them 
most commonly located in cervical and 
thoracic spinal segments3, while other 
considered that conus medullaris and cauda 
equina are more affected4. 
They usually occur in the fifth or the sixth 
decades of life.1,3,4 Men are more commonly 
affected compared with women are white race 
is more affected.1,4 Risk factors for occurrence 
of lymphomas are immune depression, such 
as: AIDS, congenital immune deficiency, 
cancer, organ transplant related immune 
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suppression, infection with Epstein-Barr virus, 
etc. 
Intramedullary lymphomas usually appear 
as a solid, homogenously enhancing mass, 
isointense in T1W and hyperintense in T2W.5 
CSF cytology shows increased cellularity.3  
Treatment of spinal lymphomas usually 
consists of surgical biopsy to establish a 
positive diagnosis, followed by adjuvant 
radiotherapy. Chemotherapy is controversial. 
Prognosis is poor, 2 years survival rate is 
32-36%.1,4 
Case report 
A 43 years old man was admitted in our 
department with spinal cord compression with 
neurological level T1, Frankel C severe right > 
left and loss of consciousness. The patient was 
immune competent and had no relevant 
medical history.  
Neurologic exam showed paraparesis, right 
L2 ASIA 2, right L3 ASIA 2, right L4 ASIA 1+, 
right L5 ASIA 1+, right S1 ASIA 3-, left L2 
ASIA 3-, left L3 ASIA 3-, left L4 ASIA 3-, left 
L5 ASIA 3- and left S1 ASIA 3. Total motor 
score on the right side was 34 and on the left 
was 40. We also found hypoesthesia with level 
T1, bilateral diminished osteotendinous 
reflexes, bilateral Babinski sign and urinary 
incontinence. 
Spinal MRI revealed two solid 
intramedullary tumours hyperintense in T1W 
and isointense in T2W, contrast enhancing. 
The first intramedullary tumour was located 
right posterolateral at T1 level, had an 
important exophytic expansion sizing 
27/13/12.5 mm, compressing and pushing the 
spinal cord to the left. It had an associated 
syringomyelia extending upwards to C4 and 
inferiorly to T7. The second tumour was also 
intramedullary exophytic, located left 
posterolateral at level T3 and measured 5/4 
mm. (Figure 1) 
Thoracic spine X-ray showed no 
radiological changes of vertebral bodies.   
Cerebral MRI showed a right temporo-
mesial infiltrative tumour.  
Blood workout, EKG and pulmonary X-ray 
showed no relevant changes.  
The patient underwent surgery. We 
performed a longitudinal midline skin 
incision, from C5 to T5 and bilateral 
subperiosteal skeletonization of paravertebral 
muscle from C7 to T4. We performed T1-T3 
laminectomies and midline dural incision. We 
found two intramedullary infiltrative tumours 
with exophytic components, one located right 
paramedian at level T1, measuring 2.5/1.5 cm 
in diameter and another located left 
paramedian at level T3, measuring 0.5/0.5 cm. 
We performed total resection of T1 tumour 
and near total resection of T3 tumour. 
Haemostasis. Dural closure. Epidural external 
drainage. Wound closure.  
Histopathological exam from both spinal 
tumours found malignant non-Hodgkin 
lymphoma. (Figure 2) 
Postoperative outcome was favourable, 
without any additional neurological deficits. 
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He received dexamethasone 24 mg / d. He 
began rehabilitation the second day after 
surgery. He underwent adjuvant radiotherapy.  
Two months later, the patient was 
readmitted with seizures, headache and 
diplopia. Neurological exam showed 
paraparesis, right L2 ASIA 3+, right L3 ASIA 
3+, right L4 ASIA 3, right L5 ASIA 3, right S1 
ASIA 4-, left L2 ASIA 4, left L3 ASIA 4, left L4 
ASIA 4 and left L5 ASIA 4. Total motor score 
on the right side was 41 and on the left was 46. 
He also had pain and temperature 
hypoesthesia with level T3 and full sphincter 
control.  
Spinal MRI showed dural contrast 
enhancement from C3 to T8 and numerous 
micronodular lesions from T2 to T10, 
suggestive for drop metastases. The largest 
lesion sizing 7/8 mm was located at T3 level. 
(Figure 3) 
Thoracic spine X-ray showed T1-T3 
laminectomies and no radiological changes of 
vertebral bodies.   
Cerebral MRI showed bilateral cerebellar 
drop metastases, measuring 0.98 cm on the 
right and 0.92 cm on the left and right 
temporo-mesial tumour hypointense in T1W 
and hyperintense in T2W and FLAIR, without 
contrast enhancement. (Figure 4) 
The patient underwent second surgery and 
we performed stereotactic biopsy of the right 
temporo-mesial tumour. Histopathological 
exam revealed diffuse infiltrative astrocytoma 
grade II WHO. 
For the third surgery, performed under the 
same general anaesthesia, we performed a 
minimal left suboccipital craniectomy. Dural 
mater was cut in X. We found a cortical 
tumour located immediately inferior to the 
transverse sinus. We performed total resection 
of a tumour 1 cm in diameter. Haemostasis. 
Dural closure. Epidural drainage. Wound 
closure. Histopathological exam revealed 
malignant non-Hodgkin lymphoma. 
Postoperative outcome was favourable; the 
patient presented no additional neurological 
deficits. Under antiepileptic therapy 
(carbamazepin 200 mg x 3 / d) the patient 
presented no seizures.  
At 6 months follow-up the patients had 
paraparesis right L2 ASIA 4-, right L3 ASIA 4-, 
right L4 ASIA 4, right L5 ASIA 4, left L2 ASIA 
4+, left L3 ASIA 4+ and left L4 ASIA 4+.  
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Figure 1. Spinal MRI. Right posterolateral T1 intramedullary with exophytic mass; polar syringomyelia from C4 
to T7; left posterolateral T3 intramedullary tumour with exophytic component 
 
 
Figure 2. Histopathological exam. Malignant B-cell non-Hodgkin lymphoma. (HE stain, 20x) 
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Figure 3. Spinal MRI. Dural contrast enhancement from C3 to T8; micronodular drop metastases micronodular 
T2 to T10 
 
 
Figure 4. Cerebral MRI. Right temporo-mesial non-enhancing tumour; cerebellar drop metastases 
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TABLE I 
Primary intramedullary lymphomas 
No. Author, year of publication No. of 
cases 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
Bruni J et al., 1977 10 
Mitsumoto H et al, 1980 11 
Hautzer NW et al., 1983 3 
Itami J et al., 1986 12 
Landan I et al., 1987 13 
Slowik F et al., 1990 14 
Wong Chung ME et al., 1991 15 
McDonald AC et al., 1995 16 
Urasaki E et al., 1996 8 
Caruso PA et al., 1998 17 
Bekar A et al., 2001 18 
Nakamizo T et al, 2002 5 
Peltier J et al., 2007 19 
Machiya T et al., 2007 20 
Matsuyama Y et al., 2009 21 
Flanagan EP et al., 2011 4 
Lin YY et al., 2012 22 
Bhushanam TV et al., 2014 23 
Sivri M et al., 2015 2 
Guzzetta M et al., 2015 6 
Yang W et al., 2017 1 
Our case, 2018  
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
2 
1 
1 
3 
14 
1 
1 
1 
1 
346 
1 
Discussions 
Primary intramedullary lymphomas are 
rare. So far, besides the two clinical studies 
reported by Yang et al.1 and Flanagan et al.4, 
only case reports have been described in the 
literature. (Table 1) 
Being so rare, the diagnostic of patients 
without spinal cord compression syndrome is 
often delayed4, so we must keep in mind this 
diagnosis to insure a prompt diagnosis and 
initiate appropriate therapy. Spinal 
lymphomas must be always suspected in 
immunocompromised patients. 
Histopathologic diagnosis is made after 
surgery (tumour resection or biopsy) or at 
autopsy. According to WHO classification, the 
vast majority are B-cell non-Hodgkin 
lymphomas, with subgroups diffuse large B-
cells and follicular being the most frequent.1 T-
cell lymphomas are extremely rare, 
representing only 1.4% of primary 
intramedullary spinal lymphomas.1,6-8 Other 
histopathological types that can be found are 
small B-cell, Burkitt, precursor cells and 
unspecified. Primary intramedullary Hodgkin 
lymphoma is exceptionally rare.1  
Nowadays the diagnosis is made on MRI. 
Spinal lymphomas are hyperintense in T2W, 
in contrast with cranial lymphomas which are 
isointense. Multifocal lesions with contrast 
enhancement are pathognomonic for spinal 
lymphomas. CSF increased cellularity have no 
specific pattern. Even though MRI was 
suggestive for a subdural extramedullary 
tumour, intraoperative findings showed that 
the tumour was in fact intramedullary with 
massive exophytic component. The exophytic 
mass was contiguous with an intramedullary 
tumour and presented no other attachment to 
any structure.  
Differential diagnosis is made with other 
intramedullary tumours: astrocytomas, 
ependymomas, epidermoid and dermoid 
tumours, metastases, hemangioblastomas, 
spinal embryonal tumours, multiple sclerosis. 
Treatment consists from surgery, for 
establishing positive diagnosis and spinal cord 
decompression, concomitant high-dose 
corticosteroids, followed by adjuvant 
radiotherapy and chemotherapy.  
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Surgery is the first step in treatment of 
patients with spinal cord tumours. The goals 
of surgery are obtaining tissue for 
histopathological diagnosis, achievement of 
maximum tumour removal without inducing 
new neurological deficits and preservation of 
spinal stability. In lymphomas, if the tumour is 
small and does not cause spinal cord 
compression, there is no need to perform total 
resection, a biopsy being sufficient. If the 
tumour is large and compresses the spinal 
cord, surgical cytoreduction immediately 
reduces compression. Tumoral cytoreduction 
may also be beneficial for adjuvant therapy. 
Surgical decompression improves 
neurological outcome and survival.9 
We performed a posterior approach, 
through T1, T2, T3 laminectomies. In this way 
we were able to gain access to both lesions. 
Although the patients had bipolar 
syringomyelia extending from C4 to T7, there 
is no need to address it, because it is secondary, 
and after tumour resection the syrinx will 
regress.  
There are several ways to resect an 
intramedullary tumour. The most used 
surgical route is posterior midline myelotomy. 
This is a safe anatomic area. Keeping the 
midline does not induce neurological damage 
to surrounding structures. This approach is 
widely used in all intramedullary tumours, 
especially in those who have no expression on 
the cord surface. In some cases, when the 
tumour causes cord distortion keeping within 
the midline may be challenging. Tumours that 
come in contact with the cord surface and are 
not infiltrative display normal structures and 
can be approach through this safe zone. 
Exophytic tumours have an important part 
situated outside the cord. This part is resected 
first and then the approach can be done 
through the area where exophytic part of the 
tumour exited the cord. Intramedullary 
tumours can be either well-defined or 
infiltrative. In well-defined tumours the 
resection is made within the cleavage plane 
and complete resection is possible, in 
infiltrative lesions there is no such plane of 
demarcation and only subtotal or near-total 
resection is possible. We choose to resect the 
exophytic component and then enter the cord 
through this safe area and resect the 
intramedullary part from inside out. The 
larger the tumour, and more precisely the 
larger the area of effraction of the cord, the 
bigger is the surgical corridor, this is why the 
bigger tumour could be totally resected and 
the small one cannot. However, total resection 
is not needed in lymphomas and the tumour 
situated at T3 level was not causing 
compression on the spinal cord. 
Intraoperative somatosensory and motor 
evoked potentials are very useful to monitor 
the effects on spinal cord induced by surgical 
gestures.  
We did not consider necessary to perform 
osteosynthesis of the spinal column because 
the spinal thoracic column is stable and we 
performed only three laminectomies, with 
complete preservation of articular facets.  
Lymphomas have a high sensibility to 
corticosteroids and immediately after 
initiating the therapy neurological 
improvement occurs. Combined adjuvant 
oncologic therapy with radio and 
chemotherapy is more effective than either of 
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them used alone. Chemotherapy consists of 
cyclophosphamide, vincristine, doxorubicin, 
methotrexate, cytarabine, rituximab, 
vincristine. 
Lymphomas of the CNS display a highly 
aggressive behaviour, are prone to disseminate 
and drop metastases can be found along the 
neuraxis, intracranial or spinal. Two months 
after surgery, our patient came with two drop 
metastases in the posterior fossa and 
numerous at the spinal level. Despite 
radiotherapy and chemotherapy, the 
prognosis is poor. Median survival rate is 6-9 
months, and 2 years survival is 32-36%.1,4 
Young age, early diagnosis, low stage, follicular 
histologic type are positive prognostic factors.1 
Conclusions 
The diagnosis of primary intramedullary 
spinal lymphoma must be kept in mind in 
patients with myelopathy. Surgery is needed to 
provide histopathological samples for positive 
diagnosis and spinal decompression. Rapid 
surgical decompression, corticosteroids and 
adjuvant radiotherapy improve neurological 
outcome. Primary intramedullary spinal 
lymphomas have a propensity to disseminate 
along the neuraxis.  
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